Announcement
03 June 2024

Memorandum of Understanding signed with El Salvador to improve access to essential cancer medicines

Collaboration between the El Salvador Ministry of Health, the ATOM Coalition, and UICC members and partners marks a major step towards implementing the country’s national cancer control plan.

Dr Ronald Alfonso Pérez Escobar, from the Ministry of Health of El Salvador, speaking at a reception of the Access to Oncology Medicines (ATOM) Coalition held at the offices of UICC on Tuesday 28 May during the World Health Assembly. El Salvador is one of the countries where the ATOM Coalition is prioritising its efforts to help ensure that the right cancer medicines reach the right patients at the right time.

UICC is thrilled to announce that a Memorandum of Understanding (MoU) has been signed between UICC and the Ministry of Health of El Salvador on behalf of the Access to Oncology Medicines (ATOM) Coalition.

The first MoU for the UICC-led ATOM Coalition was signed in February 2024 with Mongolia. This second MoU promises to enhance the availability of quality-assured oncology medicines in El Salvador.

With a population of over 6.5 million people, El Salvador reports over 9,600 new cancer cases annually – primarily prostrate and breast cancer. This collaboration between the El Salvador Ministry of Health, the ATOM Coalition, and UICC members and partners marks a major step towards implementing the country’s national cancer control plan. 

It’s tragic when a medicine exists to treat a cancer but is unavailable to a patient who needs it because of where they live. This Memorandum of Understanding means that now more people in El Salvador will be able to receive appropriate cancer treatment. It means that lives will be saved.”
Dr Dan Milner, Executive Director of the ATOM coalition.

The ATOM Coalition was launched by UICC in May 2022, and now counts over 40 partners across private and civil society sectors. Its objective is to improve availability, affordability and access to essential cancer medicines in 46 low- and lower middle-income countries.

Last update

Wednesday 06 November 2024

Share this page

Related content

Headshot of Asian woman in blue dress

Natasha Shah brings over two decades of oncology and global health leadership to her new role, dedicated to expanding access to cancer medicines in underserved regions.

Collage of different faces and people smiling

The UICC-led Access to Oncology Medicines (ATOM) Coalition has launched its first series of Health Financing Case Studies, providing insights into how low- and lower-middle-income countries (LLMICs) are financing cancer care – and where targeted adjustments can strengthen access to essential medicines and diagnostics.